These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30465472)

  • 1. Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
    Mazoochi T; Karimian M; Ehteram H; Karimian A
    Per Med; 2019 Jan; 16(1):67-78. PubMed ID: 30465472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects.
    Xu M; Hu X; Zhang M; Ge Y
    Gene; 2020 Apr; 733():144268. PubMed ID: 31809840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
    Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C
    PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
    Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.
    Xu L; Zhou X; Xu L; Yin R
    Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: A systematic review and meta-analysis.
    Fan S; Meng J; Zhang L; Zhang X; Liang C
    Pathol Res Pract; 2019 Jan; 215(1):151-158. PubMed ID: 30463805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of survivin polymorphisms with tumor susceptibility: a meta-analysis.
    Zhu Y; Li Y; Zhu S; Tang R; Liu Y; Li J
    PLoS One; 2013; 8(9):e74778. PubMed ID: 24098667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA
    Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tumor necrosis factor-α 308G/A polymorphism with urogenital cancer risk: a systematic review and meta-analysis.
    Cai J; Yang MY; Hou N; Li X
    Genet Mol Res; 2015 Dec; 14(4):16102-12. PubMed ID: 26662402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
    Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
    Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an
    Karimian M; Aftabi Y; Mazoochi T; Babaei F; Khamechian T; Boojari H; Nikzad H
    EXCLI J; 2018; 17():479-491. PubMed ID: 30034311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.
    Lin YC; Hour TC; Tsai YC; Huang SP; Wu WJ; Chen CH; Pu YS; Chung SD; Huang CY
    Urol Oncol; 2017 Sep; 35(9):543.e7-543.e16. PubMed ID: 28668478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
    Ge Y; Wang Y; Shao W; Jin J; Du M; Ma G; Chu H; Wang M; Zhang Z
    Sci Rep; 2016 Sep; 6():33542. PubMed ID: 27632928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Gowtham P; Girigoswami K; Thirumalai A; Harini K; Pallavi P; Girigoswami A
    Genet Test Mol Biomarkers; 2024 Mar; 28(3):83-90. PubMed ID: 38478803
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients.
    Rahban D; Mohammadi F; Alidadi M; Ghantabpour T; Kheyli PAG; Ahmadi M
    BMC Immunol; 2019 Aug; 20(1):30. PubMed ID: 31438837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
    Chen Y; Yu X; Li T; Yan H; Mo Z
    Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.